Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial

INTRODUCTION: There are no determined treatment agents for severe COVID-19. It is suggested that methylprednisolone, as an immunosuppressive treatment, can reduce the inflammation of the respiratory system in COVID-19 patients. METHODS: We conducted a single-blind, randomised controlled clinical tri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Edalatifard, Maryam, Akhtari, Maryam, Salehi, Mohammadreza, Naderi, Zohre, Jamshidi, Ahmadreza, Mostafaei, Shayan, Najafizadeh, Seyed Reza, Farhadi, Elham, Jalili, Nooshin, Esfahani, Masoud, Rahimi, Besharat, Kazemzadeh, Hossein, Mahmoodi Aliabadi, Maedeh, Ghazanfari, Tooba, Sattarian, Mohammadreza, Ebrahimi Louyeh, Hourvash, Raeeskarami, Seyed Reza, Jamalimoghadamsiahkali, Saeidreza, Khajavirad, Nasim, Mahmoudi, Mahdi, Rostamian, Abdolrahman
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7758541/
https://ncbi.nlm.nih.gov/pubmed/32943404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.02808-2020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados